199 related articles for article (PubMed ID: 37685931)
1. Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR.
Joseph BP; Weber V; Knüpfer L; Giorgetti A; Alfonso-Prieto M; Krauß S; Carloni P; Rossetti G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685931
[TBL] [Abstract][Full Text] [Related]
2. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
Wu M; Tong CWS; Yan W; To KKW; Cho WCS
Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
[TBL] [Abstract][Full Text] [Related]
4. HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models.
Assoni G; La Pietra V; Digilio R; Ciani C; Licata NV; Micaelli M; Facen E; Tomaszewska W; Cerofolini L; Pérez-Ràfols A; Varela Rey M; Fragai M; Woodhoo A; Marinelli L; Arosio D; Bonomo I; Provenzani A; Seneci P
Adv Drug Deliv Rev; 2022 Feb; 181():114088. PubMed ID: 34942276
[TBL] [Abstract][Full Text] [Related]
5. Tandem phosphorylation of serines 221 and 318 by protein kinase Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling of HuR.
Doller A; Schlepckow K; Schwalbe H; Pfeilschifter J; Eberhardt W
Mol Cell Biol; 2010 Mar; 30(6):1397-410. PubMed ID: 20086103
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2.
Doller A; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
Mol Biol Cell; 2007 Jun; 18(6):2137-48. PubMed ID: 17392515
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.
Doller A; Akool el-S; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
Mol Cell Biol; 2008 Apr; 28(8):2608-25. PubMed ID: 18285462
[TBL] [Abstract][Full Text] [Related]
8. FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1.
David PS; Tanveer R; Port JD
RNA; 2007 Sep; 13(9):1453-68. PubMed ID: 17626845
[TBL] [Abstract][Full Text] [Related]
9. Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.
D'Agostino VG; Lal P; Mantelli B; Tiedje C; Zucal C; Thongon N; Gaestel M; Latorre E; Marinelli L; Seneci P; Amadio M; Provenzani A
Sci Rep; 2015 Nov; 5():16478. PubMed ID: 26553968
[TBL] [Abstract][Full Text] [Related]
10. Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).
Schultz CW; Preet R; Dhir T; Dixon DA; Brody JR
Wiley Interdiscip Rev RNA; 2020 May; 11(3):e1581. PubMed ID: 31970930
[TBL] [Abstract][Full Text] [Related]
11. The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation.
Meng Z; King PH; Nabors LB; Jackson NL; Chen CY; Emanuel PD; Blume SW
Nucleic Acids Res; 2005; 33(9):2962-79. PubMed ID: 15914670
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.
Fan XC; Steitz JA
EMBO J; 1998 Jun; 17(12):3448-60. PubMed ID: 9628880
[TBL] [Abstract][Full Text] [Related]
13. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
Wang Z; Bhattacharya A; Ivanov DN
PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
[TBL] [Abstract][Full Text] [Related]
14. HuR as a molecular target for cancer therapeutics and immune-related disorders.
Majumder M; Chakraborty P; Mohan S; Mehrotra S; Palanisamy V
Adv Drug Deliv Rev; 2022 Sep; 188():114442. PubMed ID: 35817212
[TBL] [Abstract][Full Text] [Related]
15. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.
Blanco FF; Preet R; Aguado A; Vishwakarma V; Stevens LE; Vyas A; Padhye S; Xu L; Weir SJ; Anant S; Meisner-Kober N; Brody JR; Dixon DA
Oncotarget; 2016 Nov; 7(45):74043-74058. PubMed ID: 27677075
[TBL] [Abstract][Full Text] [Related]
16. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
[TBL] [Abstract][Full Text] [Related]
17. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein {beta} (C/EBP{beta}) mRNA by HuR and its translocation to the cytosol.
Gantt K; Cherry J; Tenney R; Karschner V; Pekala PH
J Biol Chem; 2005 Jul; 280(26):24768-74. PubMed ID: 15863502
[TBL] [Abstract][Full Text] [Related]
18. Targeting the multifaceted HuR protein, benefits and caveats.
Zucal C; D'Agostino V; Loffredo R; Mantelli B; NatthakanThongon ; Lal P; Latorre E; Provenzani A
Curr Drug Targets; 2015; 16(5):499-515. PubMed ID: 25706256
[TBL] [Abstract][Full Text] [Related]
19. The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitro.
Kaur K; Wu X; Fields JK; Johnson DK; Lan L; Pratt M; Somoza AD; Wang CCC; Karanicolas J; Oakley BR; Xu L; De Guzman RN
PLoS One; 2017; 12(4):e0175471. PubMed ID: 28414767
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1).
Wigington CP; Jung J; Rye EA; Belauret SL; Philpot AM; Feng Y; Santangelo PJ; Corbett AH
J Biol Chem; 2015 Feb; 290(6):3468-87. PubMed ID: 25519906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
